🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to test the safety of a combination of two ant...
Status
Completed
Location
Center for Lymphoid Malignancies at CUMC
Start Date
2008-06
Trial ID
NCT00691210
Treatments Being Tested
This phase I/II trial studies the side effects of pembrolizumab and vorinos...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2015-10-08
Trial ID
NCT02538510
Treatments Being Tested
The purpose of this study is to compare a standard chemotherapy regimen of ...
Status
Unknown
Location
112 sites UK wide
Start Date
2010-05
Trial ID
NCT01554852
Treatments Being Tested
This phase I trial is studying the side effects and best dose of vorinostat...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2006-06
Trial ID
NCT00357708
Treatments Being Tested
This is an investigational study to determine the response rate of relapsed...
Status
Terminated
Location
Multiple Locations
Start Date
2004-12-01
Trial ID
NCT00126451
RATIONALE: Vorinostat may stop the growth of cancer cells by interfering wi...
Status
Terminated
Location
Stanford University
Start Date
2008-03
Trial ID
NCT00673153
Treatments Being Tested
Determine the doses and schedule appropriate for phase 2 study of sorafenib...
Status
Completed
Location
Virginia Commonwealth University/Massey Cancer Center
Start Date
2015-01-29
Trial ID
NCT02349867
This study will be a two-arm prospective 1:1 randomised controlled trial co...
Status
Completed
Location
Brighton and Sussex University Hospitals NHS Trust
Start Date
2015-11-27
Trial ID
NCT02336074
This pilot clinical trial studies the side effects and the best way to give...
Status
Completed
Location
Children's Hospital Los Angeles
Start Date
2009-02-25
Trial ID
NCT00867178
RATIONALE: Vorinostat may stop the growth of tumor cells by blocking some o...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2009-07
Trial ID
NCT00942266
Treatments Being Tested